Understanding GLP-1 Therapy and Weight Loss Plateaus GLP-1 receptor agonists (hormone-mimicking medications like semaglutide) work by increasing feelings of fullness, slowing stomach emptying, and reducing appetite
It acts as a building material, solvent, transporter, waste remover, and temperature regulator
Please be aware that prescribed medications are not meant to be taken on a permanent basis
GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
( a-c ) Representative histological images from of sections with antibody labeling for mCherry (magenta) or DCZ-induced Fos (green) and DAPI (blue) from Control (n = 4 mice) ( a ), Gs-Dreadd (n = 4 mice) ( b ), or Gq-Dreadd (n = 6 mice) ( c ) mice